Recent clinical trials of immunotherapy in non-small-cell lung cancer

被引：7
|
作者：
Gkolfinopoulos, Stavros [1 ]
Mountzios, Giannis [2 ]
机构：
[1] BOC Oncol Ctr, Med Oncol Dept, CY-2006 Nicosia, Cyprus
[2] Henry Dunant Hosp Ctr, Med Oncol Dept 2, Athens 11526, Greece
来源：
IMMUNOTHERAPY | 2019年 / 11卷 / 06期
关键词：
atezolizumab; avelumab; checkpoint inhibitors; durvalumab; ipilimumab; nivolumab; non-small-cell lung cancer; pembrolizumab; DOCETAXEL; NIVOLUMAB; INTERLEUKIN-2; ATEZOLIZUMAB; BURDEN;
D O I：
10.2217/imt-2019-0021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：461 / 466
页数：6
相关论文
共 50 条
  • [31] Management of non-small-cell lung cancer: recent developments
    Reck, Martin
    Heigener, David F.
    Mok, Tony
    Soria, Jean-Charles
    Rabe, Klaus F.
    LANCET, 2013, 382 (9893): : 709 - 719
  • [32] Immunotherapy for non-small-cell lung cancer: the past 10 years
    Vansteenkiste, Johan
    Craps, Julie
    De Brucker, Nele
    Wauters, Isabelle
    FUTURE ONCOLOGY, 2015, 11 (19) : 2681 - 2695
  • [33] Challenges of Immunotherapy in Stage IV Non-Small-Cell Lung Cancer
    Stock-Martineau, Sophie
    Magner, Kate
    Jao, Kevin
    Wheatley-Price, Paul
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : 465 - +
  • [34] First-Line Immunotherapy for Non-Small-Cell Lung Cancer
    Reck, Martin
    Remon, Jordi
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 586 - +
  • [35] Potential role of immunotherapy in advanced non-small-cell lung cancer
    de Mello, Ramon Andrade
    Veloso, Ana Flavia
    Catarina, Paulo Esrom
    Nadine, Sara
    Antoniou, Georgios
    ONCOTARGETS AND THERAPY, 2017, 10 : 21 - 30
  • [36] Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer
    Rizvi, Naiyer A.
    Peters, Solange
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1986 - 1988
  • [37] Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer
    Schoenfeld, A. J.
    Antonia, S. J.
    Awad, M. M.
    Felip, E.
    Gainor, J.
    Gettinger, S. N.
    Hodi, F. S.
    Johnson, M. L.
    Leighl, N. B.
    Lovly, C. M.
    Mok, T.
    Perol, M.
    Reck, M.
    Solomon, B.
    Soria, J. -c.
    Tan, D. S. W.
    Peters, S.
    Hellmann, M. D.
    ANNALS OF ONCOLOGY, 2021, 32 (12) : 1597 - 1607
  • [38] Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
    Sa, Huanlan
    Song, Peng
    Ma, Kewei
    Gao, Yong
    Zhang, Li
    Wang, Deqiang
    ONCOTARGETS AND THERAPY, 2019, 12 : 8151 - 8159
  • [39] Role of immunotherapy in the treatment of advanced non-small-cell lung cancer
    Rijavec, Erika
    Genova, Carlo
    Alama, Angela
    Barletta, Giulia
    Sini, Claudio
    Pronzato, Paolo
    Coco, Simona
    Dal Bello, Maria Giovanna
    Savarino, Graziana
    Truini, Anna
    Boccardo, Francesco
    Grossi, Francesco
    FUTURE ONCOLOGY, 2014, 10 (01) : 79 - 90
  • [40] CLINICAL OUTCOMES IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER TREATED IN PHASE I CLINICAL TRIALS
    Janku, F.
    Gong, J.
    Garrido-Laguna, I.
    Parsons, H. A.
    Vaklavas, C.
    Kurzrock, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S86 - S86
12345